Table 5 Toxicity in the Trial and Control Group
Toxicity | Trial (n = 69) | Control (n = 36) | P* | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
0 | I | II | III | IV | 0 | I | II | III | IV | ||
Anemia | 37 | 16 | 8 | 7 | 1 | 21 | 9 | 4 | 1 | 1 | 0.665 |
Leukopenia | 28 | 23 | 9 | 9 | 0 | 17 | 13 | 4 | 2 | 0 | 0.570 |
Thrombocytopia | 59 | 5 | 2 | 2 | 1 | 31 | 3 | 1 | 1 | 0 | 0.557 |
Nausea / Vomiting | 32 | 16 | 19 | 2 | 0 | 18 | 4 | 11 | 2 | 1 | 0.476 |
Fever | 52 | 12 | 5 | 0 | 0 | 36 | 0 | 0 | 0 | 0 | 0.000 |
Eruption | 67 | 2 | 0 | 0 | 0 | 36 | 0 | 0 | 0 | 0 | 0.274 |
Cold-like symptoms | 47 | 19 | 3 | 0 | 0 | 36 | 0 | 0 | 0 | 0 | 0.000 |
Ostealgia / Myosalgia | 46 | 21 | 2 | 0 | 0 | 36 | 0 | 0 | 0 | 0 | 0.000 |
Chill | 38 | 31 | 0 | 0 | 0 | 36 | 0 | 0 | 0 | 0 | 0.000 |
Pain in injection area | 13 | 41 | 15 | 0 | 0 | 36 | 0 | 0 | 0 | 0 | 0.000 |
Hardening, swelling and redness in injection area | 42 | 17 | 10 | 0 | 0 | 36 | 0 | 0 | 0 | 0 | 0.000 |